MedPath

Remote Endarterectomy Versus Suprageniculate Femoropopliteal Bypass

Not Applicable
Conditions
Peripheral Arterial Occlusive Disease
Atherosclerosis
Registration Number
NCT00566436
Lead Sponsor
St. Antonius Hospital
Brief Summary

The objective of this study is to compare remote superficial femoral artery endarterectomy with suprageniculate bypass surgery in the treatment of long occlusions of the superficial femoral artery. The study hypothesis is that patency rates are comparable and therefore the minimal invasive remote superficial femoral artery endarterectomy can be considered in patients presenting with a long occlusion of the superficial femoral artery.

Detailed Description

Different strategies exist in the treatment of chronic long occlusions of the superficial femoral artery and yet we still suffer a significant percentage of restenosis, re-occlusions and even major amputations, reason for continuous development of new techniques. One such technique is the recently developed minimal invasive remote endarterectomy, which shows promising patency rates and possibly less complications with earlier recovery. A more experienced and the most implemented technique is the suprageniculate femoropopliteal bypass graft, which, when using the saphenous vein, has proved durable. A randomized trial comparing both modalities was lacking so far, what makes the objective of this study a comparison of patency rates between those 2 techniques in a randomized fashion.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
126
Inclusion Criteria
  • Patients presenting with Fontaine IIB, III, IV ischemia
  • Long (>10 cm) occlusion of the superficial femoral artery, with patent popliteal artery and at least 1 patent crural vessel
  • Atherosclerotic disease
Exclusion Criteria
  • Previous operations on the superficial femoral artery
  • Radiation therapy groin/leg region
  • Diameter superficial femoral artery < 4 mm
  • Contrast allergy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
(re-)occlusion of the endarterectomized superficial femoral artery or suprageniculate femoropopliteal bypass5 year
Secondary Outcome Measures
NameTimeMethod
(a)symptomatic (re)stenosis of the superficial femoral artery or bypass for which a re-intervention was carried out5 year
major amputation of the ipsilateral leg5 year

Trial Locations

Locations (4)

Amphia Hospital

🇳🇱

Breda, Noord-Brabant, Netherlands

St Antonius Hospital

🇳🇱

Nieuwegein, Utrecht, Netherlands

Albert Schweitzer Ziekenhuis

🇳🇱

Dordrecht, Zuid-Holland, Netherlands

UMC Utrecht

🇳🇱

Utrecht, Netherlands

Amphia Hospital
🇳🇱Breda, Noord-Brabant, Netherlands

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.